Navigation Links
Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.

LAS VEGAS, March 25, 2013 /PRNewswire/ -- PharmaRoth Labs, Inc. (OTCPink: FROI) the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, announced today that the name of the company has been changed from Fero Industries, Inc. to PharmaRoth Labs, Inc. The company also relocated corporate headquarters to Las Vegas, Nevada from Canada.

Luis Lopez , CEO of PharmaRoth Labs states: "We changed the name to PharmaRoth Labs to better reflect our business. We are also in the process of changing our ticker symbol as well. In addition, we moved our official office to Nevada, as our CFO Barry Hall is located there. These changes exemplify our desire to move the company forward and be better positioned corporately. We will announce the ticker symbol change when we receive the notification. We have not changed the web address yet, but have purchased the URL of"

About Sucanon®

Sucanon® is one of only three approved drugs in the multi-billion dollar market for a class of diabetic medications called "insulin sensitizers".  Pre-clinical and clinical studies show that Sucanon® and other insulin sensitizers lower a patient's blood sugar by increasing the muscle, fat and liver's sensitivity to the body's own naturally produced insulin.  Sucanon® has been approved for prescription sale in China and Peru.  Sucanon® is also approved as an OTC treatment for Type-II diabetes by regulatory authorities in Mexico.

For further information regarding Sucanon®, please visit PharmaRoth Labs, Inc. website at

About PharmaRoth Labs, Inc.

PharmaRoth Labs, Inc. (OTCPink: FROI) is focused on diabetes prevention and treatments.  The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon®, an oral treatment for Type-II diabetes.  Sucanon® is a member of a class of diabetic medications called insulin sensitizers.  Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin.  Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.  PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon® globally.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor relations contact:

Michael Irving 
Paramount Advisors, LLC
(407) 878-5462

SOURCE PharmaRoth Labs, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lakeland Industries, Inc. Announces Completion of Line of Credit with HSBC UK
2. Fero Industries, Inc. Issues Corporate Update
3. Sun Pharmaceutical Industries, Inc. Issues Nationwide Voluntary Recall of One Lot of Nimodipine Capsules due to Crystallization of the Fill Material
4. Lower Operating Expense Augments Digital X-rays Uptake Across Industries, Finds Frost & Sullivan
5. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
6. Medicare Recipients Will Suffer from Alarming New Changes by the CMS, Says MetroStar Home Health COO Isaac Newman
7. Hospira Announces Executive Changes
8. Pharmacy Technician Certification Board Announces Certification Program Changes
9. Power Wheelchairs Supplier Highlights Upcoming Changes to Medicare Competitive Bidding Program
10. Uroplasty Announces Executive Changes In US Sales Organization
Post Your Comments:
(Date:11/30/2015)... AUSTIN, Texas , Nov. 30, 2015  Hanger, ... the amendment and restatement of the terms of its ... "Consent Solicitation") relating to its $200,000,000 aggregate principal amount ... among other things, (i) the consent fees payable pursuant ... rate on the Notes and (iii) the expiration date ...
(Date:11/30/2015)... Mexico Healthcare and Life Sciences Report 2015 . --> ... Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences ... country of over 122 million people. --> Latin ... --> It offers companies, investors, policymakers, and stakeholders with an ... largest pharma and healthcare market in Latin America ...
(Date:11/29/2015)... , Nov. 29, 2015   Royal Philips  (NYSE: ... radiology solutions at the 2015 Radiological Society of North ... at McCormick Place in Chicago . ... experience the company,s broad portfolio of integrated Diagnostic Imaging, ... to increase clinical performance, improve workflow and create a ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 2015 , ... At Grand Dental PC, their priority is to deliver quality ... dental problems, you need to turn to a dentist who listens and responds; an ... a friendly dentist who counsels you on the best ways to maintain and improve ...
(Date:11/30/2015)... ... November 30, 2015 , ... Dr. Seth D. Margulies specializes in orthodontics and ... Dr. Margulies to experience the best available orthodontic experience in the area. Dr. ... Dentist"! , Orthodontics is the branch of dentistry that specializes in the diagnosis, prevention, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... study by UPMC and KingMed Diagnostics researchers. Their review ... found that consultation with UPMC pathologists resulted in significantly altered treatment plans for ...
(Date:11/30/2015)... ... November 30, 2015 , ... Two years ago, Debbie Gregory, the CEO ... Lynch Foundation, learning Transcendental Meditation (TM). After encouraging a number of veterans to ... that she could talk the talk. , TM is becoming one of the best ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... (ASI) as their exclusive channel partner for the Nutraceutical Specialties products into oral ... the US, effective immediately. , “We are pleased to announce our expanded ...
Breaking Medicine News(10 mins):